Data completeness
0/8 — Limited
Drug data last refreshed 2w ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
UTICORT is a topical ointment containing betamethasone benzoate, a potent corticosteroid used to treat inflammatory and pruritic dermatological conditions. It works by reducing inflammation and suppressing immune response at the skin surface. The product is currently in pre-launch phase under Pfizer sponsorship.
Pre-Launch
Pre-launch stage indicates early commercial buildup phase with investment in market preparation and team expansion ahead of launch.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on UTICORT at pre-launch offers early-stage commercial opportunity with Pfizer's resources, but limited current job openings suggest hiring will accelerate closer to launch date. Career growth depends on successful market establishment in a competitive generics-heavy category.
Brand ManagerField Sales Representative
Worked on UTICORT at Pfizer? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.